Inversago Pharma
Montreal, United States· Est.
Inversago Pharma develops peripherally-acting CB1 receptor blockers for metabolic and fibrotic diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $95M
About
Inversago Pharma develops peripherally-acting CB1 receptor blockers for metabolic and fibrotic diseases.
MetabolicSmall Molecules
Funding History
1Total raised:$95M
Series B$95M